Chronic Cough

• Cough hypersensitivity and chronic cough
• ATS Patient Education: Cough in Adults
• The current and emerging treatment landscape for chronic cough
• Efficacy and safety of gefapixant, a P2X₃ receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
• Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups
• Healthcare utilization and costs in chronic cough
• Incidence and Prevalence of Cough in a Rural Health System: A 20-Year Study
• Chronic cough: new insights and future prospects
• On Chronic Cough Diagnosis, Classification, and Treatment
• Otolaryngology Aspects of Chronic Cough
• Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
• Understanding the Foundations of Chronic Cough
• American Lung Association: Chronic Cough Resources and Videos
• Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report
• European Respiratory Society Guidelines on the Diagnosis and Treatment of Chronic Cough in Adults and Children
• Translational review: Neuroimmune mechanisms in cough and emerging therapeutic targets
• Management of chronic refractory cough in adults
• Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
• The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study
• P2X3-Receptor Antagonists as Potential Antitussives: Summary of Current Clinical Trials in Chronic Cough

Pain Management

• AAFP Pain Management and Opioid Abuse: A Public Health Concern
• CDC Guideline for Prescribing Opioids for Chronic Pain – Pocket Guide
• CDC Guideline for Prescribing Opioids for Chronic Pain – Infographic
• CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022

Peyronie’s Disease

• A clinical pathway for the management of Peyronie’s disease: integrating clinical guidelines from the International Society of Sexual Medicine, American Urological Association and European Urological Association
• JAMA Patient Page: Peyronie’s Disease
• Peyronie’s Disease
• Peyronie’s disease: new paradigm for the treatment of a unique cause of erectile dysfunction

Substance Use Disorders

• NIH/National Institute on Drug Abuse – Patient Information
• Sublocade Prescribing Information
• Medication Assisted Treatment (MAT) Certification
• Substance Abuse & Mental Health Services Administration (SAMHSA) supported CME courses on prescribing opioids for chronic pain from AAAP, AOAAM, ASPMNDPT, ATTC and ASAM